Oxidative stress in prefrontal cortex of rat exposed to MK-801 and protective effects of CAPE

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 4, 2007, Pages 832-838

  Ozyurt, Birsen ^a   Ozyurt, Huseyin ^a   Akpolat, Nusret ^b   Erdogan, Hasan ^a   Sarsilmaz, Mustafa ^b  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

CAPE; MK 801; Nitric oxide; Oxidative stress; Prefrontal cortex; Schizophrenia

Indexed keywords

ADENOSINE DEAMINASE; CAFFEIC ACID PHENETHYL ESTER; CARBONYL DERIVATIVE; CATALASE; DIZOCILPINE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DECAPITATION; DRUG EFFECT; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; MALE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PREFRONTAL CORTEX; PSYCHOSIS; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CAFFEIC ACIDS; CYTOTOXINS; DIZOCILPINE MALEATE; DRUG INTERACTIONS; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; PREFRONTAL CORTEX; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 34247509195     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.01.029     Document Type: Article

References (57)

1. Aebi H. Catalase. In: Bergmeyer H.U. (Ed). Methods of enzymatic analysis (1974), Academic Press, New York 673-677
2. Akyol O., Herken H., Uz E., Fadillioglu E., Unal S., Sogut S., et al. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients: the possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 995-1105
3. Albrecht J., and Wegrzynowicz M. Endogenous neuroprotectants in ammonia toxicity in the central nervous system: facts and hypotheses. Metab Brain Dis 20 (2005) 253-263
4. Andine P., Widermark N., Axelsson R., Nyberg G., Olofsson U., Martensson E., et al. Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther 290 (1999) 1393-1408
5. Andreasen N.C., Flashman L., Flaum M., Arndt S., Swayze II V., O'Leary D.S., et al. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 272 (1994) 1763-1769
6. Barch D.M., Carter C.S., Braver T.S., Sabb F.W., MacDonald III A., Nol D.C., et al. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry 58 (2001) 280-288
7. Broadbelt K., Byne W., and Jones L.B. Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr Res 58 (2002) 75-81
8. Bubenikova-Valesova V., Balcar V.J., Tejkalova H., Langmeier M., and St'astny F. Neonatal administration of N-acetyl-l-aspartyl-l-glutamate induces early neurodegeneration in hippocampus and alters behaviour in young adult rats. Neurochem Int 48 (2006) 515-522
9. Bueno A., De Olmos S., Heimer L., and De Olmos J. NMDA-antagonist MK-801-induced neuronal degeneration in Wistar rat brain detected by the Amino-Cupric-Silver method. Exp Toxicol Pathol 54 (2003) 319-334
10. Chen J.H., Shao Y., Huang M.T., Chin C.K., and Ho C.T. Ýnhibitory effect of caffeic acid phenethyl ester on human leukemia HL-60 cells. Cancer Lett 108 (1996) 211-214
11. Corso T.D., Sesma M.A., Tenkova T.I., Der T.C., Wozniak D.F., Farber N.B., et al. Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res 752 (1997) 1-14
12. Cortas N.K., and Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36 (1990) 1440-1443
13. Deutsch S.I., Rosse R.B., Billigslea E.N., Bellack A.S., and Mastropaolo J. Topiramate antagonizes MK-801 in an animal model of schizophrenia. Eur J Pharmacol 449 (2002) 121-125
14. Esterbaur H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hyroxynonenal, In: Packer L, Glazer AN, (Eds 9). Methods in Enzimology, V 186, Oxygen Radicals in Biological systems, NewYork: Academic Press, 1990; 407-421.
15. Eyjolfsson E.M., Brenner E., Kondziella D., and Sonnewald U. Repeated injection of MK801: an animal of schizophrenia?. Neurochem Int 48 (2006) 541-546
16. Fix A.S., Horn J.W., Wightman K.A., Johnson C.A., Long G.G., Storts R.W., et al. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-d-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp Neurol 123 (1993) 204-215
17. Giusti G. Adenosine deaminase. In: Bergmeyer M.V. (Ed). Methods of enzymatic analysis. second edition (1974), Academic Press, New York 1092-1098
18. Herken H., Uz E., Ozyurt H., Sogut S., Virit O., and Akyol O. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry 6 (2001) 66-73
19. Horrobin D.F. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30 (1998) 193-208
20. Horrobin D.F., Manku M.S., Hillman H., Lain A., and Glen M. Fatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry 30 (1991) 795-805
21. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283 (1999) 70-74
22. Ilhan A., Akyol O., Gurel A., Armutcu F., Iraz M., and Oztaş E. Protective effects of caffeic acid phenethyl ester against experimental allergic encephalomyelitis-induced oxidative stress in rats. Free Radic Biol Med 37 (2004) 386-394
23. Irmak M.K., Koltuksuz U., Kutlu N.O., Yaǧmurca M., Ozyurt H., Karaman A., et al. The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with alpha-tocopherol in rat kidneys. Urol Res 29 (2001) 190-193
24. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148 (1991) 1301-1308
25. Johnson K.M., Phillips M., Wang C., and Kevetter G.A. Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex. J Neurosci Res 52 (1998) 709-722
26. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. In: Packer L., and Glazer A.N. (Eds). Methods in enzimology. Oxygen radicals in biological systems vol. 186 (1990), Academic Press, New York 464-478
27. Lohr J.B. Oxygen radicals and neuropsychiatric illness: some speculations. Arch Gen Psychiatry 48 (1991) 1097-1106
28. Lowry O., Rosenbraugh N., Farr L., and Rondal R. Protein measurements with the folin-phenol reagent. J Biol Chem 183 (1951) 265-275
29. Mahadik S.P., Evans D., and Lal H. Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 25 (2001) 463-493
30. Mahadik S.P., Pillai A., Joshi S., and Foster A. Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia. Int Rev Psychiatry 18 (2006) 119-131
31. Mastropaolo J., Rosse R.B., and Deutsch S.I. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia. Behav Brain Res 153 (2004) 419-422
32. Mates J.M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153 (2000) 83-104
33. Mates J.M., Perez-Gomez C., and Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 32 (1999) 595-603
34. Moghaddam B., Adams B., Verma A., and Daly D. Activation of glutamatergic neurotransmission by ketamine. A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17 (1997) 2921-2927
35. Murphy S., Simmons M.L., Agullo L., Garcia A., Feinstein D.L., Galea E., et al. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 16 (1993) 323-328
36. Noelker C., Bacher M., Gocke P., Wei X., Klockgether T., Du Y., et al. The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity. Neurosci Lett 383 (2005) 39-43
37. O'Donnell P., and Grace A.A. Dysfunction in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr Bull 24 (1998) 267-283
38. Olney J.W., Labruyere J., and Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244 (1989) 1360-1362
39. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33 (1999) 523-533
40. Ozyurt B., Iraz M., Koca K., Ozyurt H., and Sahin S. Protective effects of caffeic acid phenethyl esteron skeletal muscle ischemia-reperfusion injury in rats. Mol Cell Biochem 292 (2006) 197-203
41. Ozyurt B., Sarsilmaz M., Akpolat N., Ozyurt H., Akyol O., Herken H., et al. The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat. Neurochem Int 50 (2007) 196-202
42. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-170
43. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates vol. 2 (1986), Academic Press, NewYork
44. Prajda N., and Weber G. Malign transformation-linked imbalance: decreased XO activity in hepotomas. FEBS Lett 59 (1975) 245-249
45. Rajkowska G., Miguel-Hidalgo J.J., Makkos Z., Meltzer H., Overholser J., and Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 57 (2002) 127-138
46. Roth K.A., and D'Sa C. Apoptosis and brain development. Ment Retard Dev Disabil Res Rev 7 (2001) 261-266
47. Rung J.P., Carlsson A., Markinhuhta K.R., and Carlsson M.L. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 827-832
48. Sud'ina G.F., Mirzoeva O.K., Puskareva M.A., Korshunova G.A., Sumbatyan N.V., and Varfolomeev S.D. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 329 (1993) 21-24
49. Sun Y., Oberley L.W., and Ying L. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 497-500
50. Tamminga C.A., Holcomb H.H., Gao X.M., and Lahti A.C. Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. Int Clin Psychopharmacol 10 (1995) 29-37
51. Wei X., Zhao L., Ma Z., Holtzman D.M., Yan C., Dodel R.C., et al. Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury. Brain 127 (2004) 2629-2635
52. Weinberger D.R., Berman K.F., and Illowsky B. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: III. A new cohort and evidence for a monoaminergic mechanisms. Arch Gen Psychiatry 45 (1988) 609-615
53. Willis C.L., and Ray D.E. Antioxidants attenuate MK-801-induced cortical neurotoxicity in the rat. Neurotoxicology 28 (2007) 161-167
54. Yao J.K., Reddy R.D., and van Kammen D.P. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15 (2001) 287-310
55. Yao J.K., Leonard S., and Reddy R.D. Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr Bull 30 (2004) 923-934
56. Zhang X., Boulton A.A., Zuo D.M., and Yu P.H. MK-801 induces apoptotic neuronal death in the rat retrosplenial cortex: prevention by cycloheximide and R(-)-2-hexyl-N-methylpropargylamine. J Neurosci Res 46 (1996) 82-89
57. Zuo D.Y., Wu Y.L., Yao W.X., Cao Y., Wu C.F., and Tanaka M. Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis. Pharmacol Biochem Behav 86 (2007) 1-7